ArticleClinical pharmacokinetics2022

Yes We Can (Use Nirmatrelvir/Ritonavir Even in High Immunological Risk Patients Treated with Immunosuppressive Drugs)!

Florian LemaitrePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.